Idenix Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Merck Completes Tender Offer To Acquire Idenix
Article By: Dr. Hung Tran
Tuesday, August 5, 2014 4:02 PM EDT
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) at a purchase price of $24.50 per share.
In this article: MRK, IDIX
Read
Frontrunning: June 10
Article By: Tyler Durden
Tuesday, June 10, 2014 9:05 AM EDT
Ukraine, Russia Fail to Reach Deal in Natural-Gas Talks (WSJ). Boko Haram Kidnaps More Girls in Nigeria (WSJ). Déjà vu: echoes of pre-crisis world mount (FT)...
In this article: ALEX, ALU, AMD, BLT, CCE, CL, CS, CVX, DEO, DUK, GM, MRK, TOT, TSN, TWC, WMT, XOM, DNDN, IDIX, BEAV, EBAY, META
Read
Merger Monday: Record Highs And A Few Crumbs
Article By: Marvin R Clark
Monday, June 9, 2014 8:34 PM EDT
Today had all the signs of a bull market, in addition to record highs, we had a good old fashioned Merger Monday. Tyson foods agreed to buy Hillshire; Drugmaker Merck paid $3.9 billion for Idenix Pharmaceuticals, a 240% premium; Chipmaker Analog Devices agreed to buy Hittite Microwave Corp.
In this article: ADI, MRK, TSN, IDIX, HITT, HSH
Read
Merck Felt Lonely In The Hepatitis C Space, Acquired Idenix Pharmaceuticals
Article By: Terry Chrisomalis
Monday, June 9, 2014 8:26 PM EDT
Today Merck paid $3.8 billion dollars to acquire Idenix Pharmaceuticals (IDIX) or $24.50 per share. Why would Merck want to acquire Idenix Pharmaceuticals if Gilead's Sovalid is already in the race and gaining a huge chunk of the Hepatitis C market? It had a good reason...
In this article: MRK, IDIX, GILD
Read
All Posts

Latest Tweets for $IDIX

No tweets yet!

PARTNER HEADLINES